Nimmagadda Prasad

Last updated

Nimmagadda Prasad
Prasad Nimmagadda.jpg
Born (1961-10-11) 11 October 1961 (age 63)
Krishna District, Andhra Pradesh, India
Education
OccupationEntrepreneur

Nimmagadda Prasad (born 11 October 1961) is an Indian industrialist from Andhra Pradesh, India. He is known for his ventures in the Pharmaceutical and Television industries, and is involved in philanthropic activities through Nimmagadda Foundation. [1] [2]

Contents

With master's degrees in Physics and Business Administration, Nimmagadda made a humble beginning as a company executive.

With over 15 years of professional experience in multinational pharmaceutical environment, Nimmagadda turned entrepreneur in the year 2000 by acquiring a sick pharmaceutical company in Hyderabad, and made it a great turnaround company, Matrix Laboratories Limited. [3] With good product innovation, manufacturing scale, leadership, global marketing footprint and M&A Strategy, Nimmagadda steered Matrix Laboratories as one of the major pharmaceutical companies in India. [4]

In a span of 6 years, Nimmagadda built Matrix to a US$1.03 billion enterprise before it was acquired by US-based Mylan N.V. in 2006. [5]

Nimmagadda has played a vital role in establishing Care Hospitals and Asian Institute of Gastroenterology (AIG), two leading healthcare centres started in Hyderabad. He served as a board member and was also an investor in both. [6]

Nimmagadda continued his entrepreneurial journey by acquiring Maa TV in 2006, along with Nagarjuna being the largest shareholder of the channel, and made it a leading Telugu General Entertainment Channel network. The revenue of the company has grown to ₹3.5 billion (equivalent to ₹11 billionorUS$130 million in 2023) in 7 years. [7]

In 2015, Maa TV was acquired by Star India, a wholly owned subsidiary of Rupert Murdoch-owned 21st Century Fox for a consideration of about ₹23 billion (equivalent to ₹35 billionorUS$420 million in 2023). [8]

In 2008, Nimmagadda joined as a local partner with the Ras al-Khaimah for the implementing of a mega infrastructure project under the umbrella of VANPIC for the development of a world-class port-based integrated industrial corridor in the coastal region of Andhra Pradesh. This project was expected to transform the hitherto agri-based Guntur and Prakasam districts of Andhra Pradesh into major industrial hubs. [9] With regards to VANPIC project, Nimmagadda is embroiled in the alleged disproportionate assets case against Y. S. Jaganmohan Reddy, president of YSR Congress. [10]

Currently, Nimmagadda has forayed into sports as a business by partnering with Sachin Tendulkar, Chiranjeevi and Allu Arvind. [11] Their Consortium owns teams across different sports:

The consortium actively promotes grassroots and youth development programs for all these sports. [16]

Nimmagadda contributed substantially towards the establishment of Pullela Gopichand’s badminton academy in its formative years. [17]

In 2006, Nimmagadda sold off his majority shares in Matrix Pharmaceutical to Mylan Laboratories, USA, a large generic Pharmaceutical Company. [3] For his achievements, the state government has honoured him with the "Best Management Award" in 2006. On the other hand, in 2012, he was jailed during CBI's investigation on Y. S. Jaganmohan Reddy's Disproportionate Assets, for allegedly having paid ₹8.5 billion (equivalent to ₹14 billionorUS$170 million in 2023) on a quid pro quo amounting to ₹14.26 billion (equivalent to ₹24 billionorUS$290 million in 2023) investments in VANPIC and other firms held by him, during Y. S. Rajasekhara Reddy's government. [18] [19] However, these assets were subsequently attached by the Enforcement Directorate of India, and Nimmagadda was granted bail after seventeen months. [20]

Early life

Son of an army officer, Nimmagadda obtained his BSc degree from Babu Jagjivanram Govt. College, Hyderabad, and then his MSc from the University of Delhi, [21] followed by a post graduate diploma in management from Institute of Management Technology, Ghaziabad. [22]

Nimmagadda started his career as a management trainee in Indian Molasses Company in Delhi (an associate of United Molasses Company, UK) in 1984 and was promoted to salesman at Rhone Poulenc Chemicals (the company later merged with Hoechst AG to form Aventis, and then to Vorin Laboratories as general manager of marketing in 1993, from his continuous efforts was elevated to managing director in 1995. When Indian pharma market leader Ranbaxy Ltd. acquired Vorin, Nimmagadda was re-designated Senior managing director and chief executive officer. [23]

Matrix Laboratories

In 2000, Nimmagadda took over the sick pharmaceuticals company Herren Drugs, and renamed it Matrix Laboratories, and obtained US FDA clearance for the manufacturing facilities in Hyderabad. [1] Matrix grew dramatically through a series of mergers and acquisitions. Nimmagadda acquired Medicorp Technologies in May 2003, Vorin Labs in September 2003, Vera Laboratories, Fine Drugs & Chemicals the same year 2004 and a controlling stake in Concord Biotech in 2006. Nimmagadda set his eyes on the global pharma-scape by acquiring Belgium-based Docpharma in June 2005, and a controlling stake in China's McChem Group. He also floated a JV South Africa's Aspen Pharmacare in September 2005, and picked 43% stake in Switzerland's Explora Laboratories SA the same year.

In 2006, Nimmagadda sold off his majority shares in Matrix to Mylan Laboratories, US, a large generic pharmaceutical company. From an initial investment of ₹30 million (equivalent to ₹96 millionorUS$1.2 million in 2023), [23] Nimmagadda retained 5% in Matrix, and made about ₹5.7 billion (equivalent to ₹18 billionorUS$220 million in 2023) in the transaction in which Mylan picked up a 71.5% stake in Matrix laboratories. [3]

Philanthropy

Nimmagadda implemented his belief that 'the best way to enhance knowledge and wealth is to share it' by sharing his personal wealth of 2 million shares worth around ₹300 million (equivalent to ₹960 millionorUS$12 million in 2023) with his staff for their housing and children's education through the Matrix Employees Welfare Association (MEWA). [3] [22]

Clinton Foundation's Low cost HIV drugs initiative- Nimmagadda's Matrix part of it. Clinton Foundation Nimmagadda Prasad.jpg
Clinton Foundation's Low cost HIV drugs initiative- Nimmagadda's Matrix part of it.

He is known in the social world for his contribution through “Project Hope” in developing cost effective medicines for HIV/AIDS treatment. [24] Matrix signed a major deal with the Clinton Foundation for the supply of anti-AIDS drugs as part of the latter's initiatives in Developing Countries. [25] [26] [27]

Pullela Gopichand's unwavering commitment that made his academy a powerhouse of badminton was backed and part funded by Nimmagadda. [28] In the early days when he was struggling to raise funds, Nimmagadda saw the need to develop and encourage an alternative sport to Cricket and donated ₹50 million (equivalent to ₹170 millionorUS$2.0 million in 2023) to the Pullela Gopichand academy. [29] The academy produced world class players: Saina Nehwal, Srikanth Kidambi, Parupalli Kashyap, P. V. Sindhu, Arundhati Pantawane, Gurusai Datt and Arun Vishnu.

Other investments

Subsequently, Nimmagadda invested his capital in healthcare – CARE hospitals and Asian Institute of Gastroenterology. He also invested in stent manufacturer Relisys, and some genomic research-based companies. In the media business, he invested in MAA TV.

Nimmagadda at TeachAids launch in 2010 Nimmagadda Prasad TeachAIDS 2010.jpg
Nimmagadda at TeachAids launch in 2010

Nimmagadda was on the executive board of the Indian School of Business(ISB), Hyderabad, besides his association with several academic, research and business organisations. After his arrests, he had to resign from most such posts, such as the Indian School of Business. [30]

Arrest and attachment of properties

On 17 May 2012, Nimmagadda Prasad was questioned for several days and eventually arrested by the CBI. He was lodged in Chanchalguda jail, where he was always seen carrying a bottle of mineral water. [31] After several failed attempts, he was eventually granted bail after seventeen months, in October 2013. [20]

In March 2014, in one of the largest criminal actions under the Prevention of Money Laundering Act, the Enforcement Directorate (ED) attached about 15 billion of assets of Nimmangada Prasad and his companies: G2 corporate Services Ltd, Alpha villas Pvt Ltd, Alpha Avenues Pvt Ltd, Gilchrist Investment Pvt Ltd, Suguni Constructions Pvt Ltd and Beta Avenues Pvt Ltd. [32] ED claimed that Nimmagadda had obtained illegal benefits of ₹14.26 billion (equivalent to ₹23 billionorUS$270 million in 2023) in his firms, and made the quid pro quo investment worth ₹8.55 billion (equivalent to ₹14 billionorUS$160 million in 2023) into Jagan Reddy's companies.

On 22 Sep 2016, Bahamas papers revealed that he has 28 secret companies at Secundrabad. Prasad and Prakash Nimmagadda, with interests in real estate to pharmaceuticals, is another set of names. Nimmagadda is already being probed by the Central Bureau of Investigation in another case, which had also arrested him in May 2012, and got bail 17 months later, the newspaper said.

"I would not like to discuss this issue over phone. We can meet personally and talk about it. I will tell you everything," Nimmagadda has been quoted as telling the Express. This was followed by calls by his office later canceling a total of three appointments that had been fixed, the Express said.

Despite facing challenges due to political ties and ambitious ventures, which even led to his arrest, he navigated through controversy. In a pivotal moment on July 28, 2022, the Telangana High Court dismissed the Central Bureau of Investigation charge sheet in the VANPIC case. Then, in a major breakthrough on July 7, 2023, the Enforcement Directorate liberated his assets, worth Rs 11,000 crore, from attachment, signifying his remarkable resilience amidst adversity. [33] [34]

See also

Related Research Articles

<span class="mw-page-title-main">Sachin Tendulkar</span> Indian cricketer (born 1973)

Sachin Ramesh Tendulkar is an Indian former international cricketer who captained the Indian national team. He is widely regarded as one of the greatest batsmen in the history of cricket. Hailed as the world's most prolific batsman of all time, he is the all-time highest run-scorer in both ODI and Test cricket with more than 18,000 runs and 15,000 runs, respectively. He also holds the record for receiving the most player of the match awards in international cricket. Tendulkar was a Member of Parliament, Rajya Sabha by presidential nomination from 2012 to 2018.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

<span class="mw-page-title-main">Pullela Gopichand</span> Badminton player

Pullela Gopichand is an Indian former badminton player. Currently, he is the Chief National Coach for the India national badminton team. He won the All England Open Badminton Championships in 2001, becoming the second Indian to achieve this feat after Prakash Padukone. He runs the Gopichand Badminton Academy. He received the Arjuna Award in 1999, the Khel Ratna Award in 2001, the Dronacharya Award in 2009 and the Padma Bhushan – India's third highest civilian award – in 2014. He is the only Indian coach to win the "Honorable Mention" by the International Olympic Committee at the 2019 Coaches Lifetime Achievement Awards.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Genome Valley</span> Life Sciences in Telangana, India

Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).

<span class="mw-page-title-main">Teva Pharmaceuticals</span> Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.

<span class="mw-page-title-main">Star Maa</span> Indian Telugu -language television channel

Star Maa is an Indian Telugu language general entertainment pay television channel operated by Disney Star, a subsidiary of Star India. It primarily telecasts programmes such as serials, reality shows and Telugu films.

G. V. Prasad is an Indian business executive, and co-chairman and managing director of Dr. Reddy's Laboratories. He studied chemical engineering at the Alagappa College of Technology. After completing five semesters, Prasad went on to the Illinois Institute of Technology in Chicago to complete his remaining undergraduate degree. Prasad then went on to pursue a one-year MBA at Purdue University. Prasad won the 'Outstanding Senior Student' Award from the American Institute of Chemists, Chicago chapter in 1982. He earned his master's degree in industrial administration from Purdue University in 1983.

<span class="mw-page-title-main">Heather Bresch</span> American business executive

Heather Bresch is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. Bresch has been a central figure in two controversies: a 2007 accusation of inflating her resume with an unearned MBA degree, and as the CEO of Mylan during the 2016 controversy over pricing of the company's EpiPen products. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Pullela Gopichand Badminton Academy (PGBA) is a badminton training facility in Hyderabad, Telangana, India. Founded in 2008 by the 2001 All England Open Badminton champion Pullela Gopichand, the facility trains several badminton players such as Saina Nehwal, P. V. Sindhu, Srikanth Kidambi, Parupalli Kashyap, H.S. Prannoy, Sai Praneeth, Sameer Verma.

<span class="mw-page-title-main">Prasad V. Potluri</span> Indian entrepreneur and philanthropist

Potluri Vara Prasad is an Indian serial entrepreneur. He serves as the Executive Chairman and Managing Director at PVP Ventures Ltd., as well as the Managing Director and Executive Director at Picturehouse Media Ltd.

Vadarevu and Nizampatnam Industrial Corridor (VANPIC) is an upcoming industrial park located between Guntur district and Prakasam district in Andhra Pradesh, India. It is spread over 13,000 acres. It is under CBI investigation for land acquisition and other allegation. Around 4000 acres was acquired for port development. Large tracts of land was acquired from local farmers. In April 2011, the property consultant, Jones Lang LaSalle estimated the 13,000 acres at ₹1,426 crores.

<i>Pandaga Chesko</i> 2015 Indian Telugu-language masala film

Pandaga Chesko (transl. Celebrate) is a 2015 Indian Telugu-language masala film directed by Gopichand Malineni and produced by Paruchuri Kireeti on the United Movies banner. The film stars Ram, Rakul Preet Singh and Sonal Chauhan and Sampath Raj, Abhimanyu Singh, Sai Kumar, Adithya, Brahmanandam, Rao Ramesh, Pavitra Lokesh, Tejaswi Madivada, Vennela Kishore and Raghu Babu in other important roles. The story was penned by Veligonda Srinivas and the screenplay was provided by Kona Venkat and Anil Ravipudi, with the former writing the dialogues. S. Thaman composed the music, while Sameer Reddy and Gautham Raju handled the cinematography and editing of the film, respectively.

<i>Loukyam</i> 2014 Indian film

Loukyam (transl. Wit) is a 2014 Indian Telugu-language action comedy film directed by Sriwass. The film stars Gopichand Rao Ramesh Prakash Raj Nadhiya Sunil Sayaji Shinde and Raghu Babu Vennela Kishore Nadhiya Rakul Preet. It is produced by V. Anand Prasad on Bhavya Creations banner. Kona Venkat and Gopimohan provided the screenplay form a story written by Sridhar Seepana. The film has music composed by Anup Rubens.

Concord Biotech Limited (CBL) is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide.

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

References

  1. 1 2 "List of Private Companies Worldwide, Letter – Businessweek". Investing.businessweek.com. Retrieved 17 September 2012.[ dead link ]
  2. ↑ M. Somasekhar (16 May 2012). "The rise and fall of Matrix Prasad". BusinessLine. The Hindu. Retrieved 17 September 2012.
  3. 1 2 3 4 C. R. Sukumar (29 August 2006). "Nimmagadda Prasad: 'Fastest wealth creator' in Indian pharma space". BusinessLine. The Hindu. Retrieved 19 March 2018.
  4. ↑ J. Padmapriya (21 July 2007). "Masterminded Matrix Lab's rise to the top". The Economic Times. Bennett, Coleman & Co. Retrieved 27 August 2021.
  5. ↑ "US pharma major Mylan buys Matrix Labs". The Economic Times. Bennett, Coleman & Co. 29 August 2006. Retrieved 19 March 2018.
  6. ↑ Balakrishnan, Reghu (6 July 2015). "Hinduja-Everstone consortium in race to buy CARE Hospitals". Mint. Retrieved 27 August 2021.
  7. ↑ "Telugu stars, Matrix Labs promoter to take 60% stake in Maa TV". Indian Television. 23 March 2006. Retrieved 27 August 2021.
  8. ↑ "STAR India acquires MAA TV's broadcast business for Rs 2.5k cr". Business Standard. 12 February 2015. Retrieved 27 August 2021.
  9. ↑ Annual Activity Report (PDF) (Report) (2007–2008 ed.). L V Prasad Eye Institute. 3 November 2008. Retrieved 27 August 2021.
  10. ↑ Sharma, E. Kumar (12 February 2015). "Maa TV's Nimmagadda Prasad hits the jackpot again". Business Today. India Today Group. Retrieved 27 August 2021.
  11. ↑ "Chiranjeevi, Nagarjuna join Tendulkar as Blasters co-owners". The Times of India. Bennett, Coleman & Co. Press Trust of India. 1 June 2016. Retrieved 27 August 2021.
  12. ↑ "Sachin Tendulkar becomes co-owner of PBL franchise". The Indian Express. Press Trust of India. 9 December 2016. Retrieved 27 August 2021.
  13. ↑ "Premier Badminton League 2017: Sachin Tendulkar Picks Up Stake in Bengaluru Blasters". News18. Press Trust of India. 8 December 2016. Retrieved 27 August 2021.
  14. ↑ "Sachin Tendulkar owns team in Pro Kabbadi League". The New Indian Express. Press Trust of India. 12 May 2017. Retrieved 27 August 2021.
  15. ↑ Choudhary, Vidhi (12 May 2017). "Sachin Tendulkar, JSW, Adani among owners of new Pro Kabaddi League teams". Mint. Retrieved 27 August 2021.
  16. ↑ "Hyderabad Football Academy, Kerala Blasters to groom talent". BusinessLine. The Hindu. 17 August 2017. Retrieved 27 August 2021.
  17. ↑ V. V. Subrahmanyam (12 May 2017). "Why kabaddi, why Chennai? Tendulkar explains". The Hindu. Retrieved 27 August 2021.
  18. ↑ "Jagan Mohan Reddy's judicial custody extended". NDTV. Press Trust of India. 13 August 2013. Retrieved 27 August 2021.
  19. ↑ Janyala, Sreenivas (17 May 2012). "Prasad put Rs 850 cr in Jagan firms: CBI". The Indian Express. Retrieved 27 August 2021.
  20. 1 2 "Quid-pro-quo case: Nimmagadda Prasad, K V Brahmananda get bail". DNA. Diligent Media Corporation. Press Trust of India. 7 October 2013. Retrieved 27 August 2021.
  21. ↑ "Nimmagadda Prasad who?". The Financial Express. The Indian Express. 2 September 2006. Retrieved 27 August 2021.
  22. 1 2 "Nimmagadda Prasad, a first generation entrepreneur". The Hindu. 16 May 2012. ISSN   0971-751X . Retrieved 17 September 2012.
  23. 1 2 B. Krishna Prasad (19 August 2011). "Who is Matrix Prasad?". Times of India.
  24. ↑ "Nimmagadda Prasad joins TeachAids Advisory Board". TeachAids. 16 June 2010. Retrieved 19 March 2018.
  25. ↑ G. Singa Rao (3 January 2004). "Matrix revolutions". Business Standard. Retrieved 19 March 2018.
  26. ↑ Angelillo, John (6 August 2009). Former President Bill Clinton, Pfizer and Mylan announce lower prices for HIV Drugs in Developing Countries in New York (Photo). United Press International. Retrieved 19 March 2018.
  27. ↑ "Clinton Foundation, Global Fund, World Bank, UNICEF Extend Low-Cost Generic AIDS Drug Prices to More Than 100 Countries". Kaiser Health News. 6 April 2004. Retrieved 19 March 2018.
  28. ↑ M. Ratnakar (11 August 2013). "How Gopichand made Hyderabad India's badminton capital". The Times of India. Bennett, Coleman & Co. Times News Network. Retrieved 27 August 2021.
  29. ↑ Amirapu, Deepika (20 August 2016). "How Indian badminton rocketed on the Gopichand shuttle". Thread. The Hindu. Retrieved 27 August 2021.
  30. ↑ M. Rajeev (20 June 2012). "B-school frets over one-time mentor's plight". The Hindu. Retrieved 27 August 2021.
  31. ↑ Koppula, Nagaraju (6 June 2012). "Balance in Jagan's jail Account: Rs 2,900". The New Indian Express. Retrieved 27 August 2021.
  32. ↑ "Enforcement Directorate attaches Rs 863 crore assets of Jaganmohan Reddy, others for laundering". The Economic Times. Bennett, Coleman & Co. Press Trust of India. 5 March 2014. Retrieved 27 August 2021.
  33. ↑ "Vanpic case: HC strikes down CBI charge sheet". 28 July 2022.
  34. ↑ "Court releases 11,000 acres attached by ED". The Times of India . 9 July 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.